OncoBeta® GmbH is pleased to announce the acceptance of the invitation to speak at the World Rhenium Congress hosted by the Dept. of Nuclear Medicine, KMCH in Coimbatore, India. Dr. Thomas Wendler, one of the managing directors at OncoBeta will speak about their new therapy for Non-Melanoma Skin Cancer Rhenium-SCT®. The Rhenium-SCT® (Skin Cancer Treatment) utilizing Rhenium-188 is ideal for the targeted local treatment of superficial non-melanoma skin cancers up to 3mm in depth. The Rhenium-SCT is a painless, non-invasive therapy that is designed to target and destroy cancer cells bringing back the quality of life for non-melanoma skin cancer patients. This is a new exiting area of therapy for the nuclear medicine.
There will be three conferences back to back starting off with the 23rd Annual conference of Society of Nuclear Medicine India (Southern Chapter) 2017 on 12th & 13th of August 2017 followed by the ISCORN session, The 2nd World Rhenium Congress on the 14th & 15th August 2017 and then ending with the WARMTH Theranostic academy(WTA) meeting on the 15th & 16th August 2017.
More information about the Rhenium-SCT® can be found at www.oncobeta.com